Overview
Marco Annandale practices practicing medicine in Auckland, New Zealand.
His clinical expertise encompasses Cardiomyopathy, Collagen VI-Related Myopathy, and Maturity Onset Diabetes of the Young.
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marco Annandale
Is Marco Annandale a top-rated expert for Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Marco Annandale is classified as an Experienced expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marco Annandale participate in research or clinical trials?
Yes. Marco Annandale has published 14 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Marco Annandale's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CardiomyopathyMr. Annandale isExperienced. Learn about Cardiomyopathy.
- Collagen VI-Related MyopathyMr. Annandale isExperienced. Learn about Collagen VI-Related Myopathy.
- Maturity Onset Diabetes of the YoungMr. Annandale isExperienced. Learn about Maturity Onset Diabetes of the Young.